RIGL Financing Cash Flow

Rigel Pharmaceuticals Inc · Financing Cash Flow

RIGL logo

RIGL Financing Cash Flow

Latest reported-$22.92M
RIGL TTM Cash from Financing (-$411.00K → -$22.92M)
High-resolution chart · PNG

RIGL financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-22,921,000
-10,802,000
601,000
6,638,000
-7,475,000
-8,645,000
-11,641,000
-12,620,000
-3,647,000
-3,268,000
18,367,000
15,785,000
22,165,000
16,876,000
6,550,000
9,731,000
4,494,000
69,375,000
62,675,000
62,257,000
62,035,000
13,332,000
12,571,000
12,598,000
22,345,000
12,685,000
11,365,000
11,770,000
2,606,000
69,899,000
71,894,000
138,161,000
140,863,000
76,275,000
117,688,000
52,357,000
62,202,000
68,604,000
25,184,000
29,075,000
15,991,000
7,040,000
7,053,000
1,607,000
1,514,000
1,163,000
1,170,000
919,000
914,000
1,075,000
1,051,000
137,347,000
138,543,000
138,606,000
139,094,000
3,338,000
2,163,000
142,666,000
141,979,000
141,716,000
141,661,000
858,000
820,000
890,000
102,495,000
102,256,000
102,155,000
103,160,000
2,036,000
3,253,000
131,990,000
134,562,000
133,898,000
185,154,000
56,776,000
53,095,000
54,237,000
2,147,000
2,836,000
18,410,000
99,028,000
98,670,000
103,605,000
93,348,000
12,927,000
12,503,000
64,831,000
58,753,000
66,116,000
111,162,000
52,832,000
52,227,000
43,280,000
-1,126,000
30,084,000
30,688,000
30,491,000
30,711,000
-411,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.